Cargando…
Budesonide repairs decreased barrier integrity of eosinophilic nasal polyp epithelial cells caused by PM(2.5)
BACKGROUND: Eosinophilic chronic rhinitis with nasal polyps (eos‐CRSwNP) is a subtype of nasal polyps (NPs) characterized by severe type‐2 inflammation and defective epithelial barrier function. The epithelial barrier plays important roles in the pathogenesis of NPs and type‐2 inflammation. Particul...
Autores principales: | Ma, Siyuan, Xian, Mu, Wang, Yang, Wang, Chengshuo, Zhang, Luo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254582/ https://www.ncbi.nlm.nih.gov/pubmed/34262692 http://dx.doi.org/10.1002/clt2.12029 |
Ejemplares similares
-
Investigation of the Value of T(2) Mapping in the Prediction of Eosinophilic Chronic Rhinosinusitis With Nasal Polyps
por: Wang, Yuchen, et al.
Publicado: (2023) -
Particulate Matter 2.5 Causes Deficiency in Barrier Integrity in Human Nasal Epithelial Cells
por: Xian, Mu, et al.
Publicado: (2019) -
Predictive significance of arachidonate 15-lipoxygenase for eosinophilic chronic rhinosinusitis with nasal polyps
por: Liang, Zhuoping, et al.
Publicado: (2020) -
Eosinophilic cholangitis treatment with budesonide
por: De Roza, Marianne Anastasia, et al.
Publicado: (2017) -
Sinus Microbiota in Patients With Eosinophilic and Non-Eosinophilic Chronic Rhinosinusitis With Nasal Polyps
por: Feng, Tingting, et al.
Publicado: (2021)